Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Recent studies have indicated that CD30 is frequently expressed in aggressive systemic mastocytosis and mast cell leukemia but infrequently in indolent systemic mastocytosis, and may be a useful marker for distinguishing these subtypes of systemic mastocytosis from one another.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP573574.RASe8v6mLGs0aIpWjfmko4rB0ZK-vHh1dHcTivoUM_TFk130_assertion description "[Recent studies have indicated that CD30 is frequently expressed in aggressive systemic mastocytosis and mast cell leukemia but infrequently in indolent systemic mastocytosis, and may be a useful marker for distinguishing these subtypes of systemic mastocytosis from one another.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573574.RASe8v6mLGs0aIpWjfmko4rB0ZK-vHh1dHcTivoUM_TFk130_provenance.
• NP787985.RAdhO9e1xhGG2ijlj0KH0jW5KksTlVX_o2PdwzbC3k7_I130_assertion description "[Recent studies have indicated that CD30 is frequently expressed in aggressive systemic mastocytosis and mast cell leukemia but infrequently in indolent systemic mastocytosis, and may be a useful marker for distinguishing these subtypes of systemic mastocytosis from one another.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787985.RAdhO9e1xhGG2ijlj0KH0jW5KksTlVX_o2PdwzbC3k7_I130_provenance.
• NP292163.RAS4zgmRbrCdIuLOwMK4nM2ffPDLgEKpiHxZRK5FkNz_k130_assertion description "[Recent studies have indicated that CD30 is frequently expressed in aggressive systemic mastocytosis and mast cell leukemia but infrequently in indolent systemic mastocytosis, and may be a useful marker for distinguishing these subtypes of systemic mastocytosis from one another.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292163.RAS4zgmRbrCdIuLOwMK4nM2ffPDLgEKpiHxZRK5FkNz_k130_provenance.
• NP964022.RAVQ1DkBSVBLcPdICGvUMRrrfPc6XanfDA0GIJwRNaZ68130_assertion description "[Recent studies have indicated that CD30 is frequently expressed in aggressive systemic mastocytosis and mast cell leukemia but infrequently in indolent systemic mastocytosis, and may be a useful marker for distinguishing these subtypes of systemic mastocytosis from one another.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964022.RAVQ1DkBSVBLcPdICGvUMRrrfPc6XanfDA0GIJwRNaZ68130_provenance.
• NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_assertion description "[Recent studies have indicated that CD30 is frequently expressed in aggressive systemic mastocytosis and mast cell leukemia but infrequently in indolent systemic mastocytosis, and may be a useful marker for distinguishing these subtypes of systemic mastocytosis from one another.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_provenance.
• NP292371.RAsBmThH3CAkbi3UY1fKm5DIApc9bJLzbZe30J7fRDmgU130_assertion description "[Recent studies have indicated that CD30 is frequently expressed in aggressive systemic mastocytosis and mast cell leukemia but infrequently in indolent systemic mastocytosis, and may be a useful marker for distinguishing these subtypes of systemic mastocytosis from one another.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292371.RAsBmThH3CAkbi3UY1fKm5DIApc9bJLzbZe30J7fRDmgU130_provenance.
• NP846494.RAMmg0gIpeLEzL4BESBE6sI6sSaNVEur78s4eEIxvAza4130_assertion description "[Recent studies have indicated that CD30 is frequently expressed in aggressive systemic mastocytosis and mast cell leukemia but infrequently in indolent systemic mastocytosis, and may be a useful marker for distinguishing these subtypes of systemic mastocytosis from one another.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP846494.RAMmg0gIpeLEzL4BESBE6sI6sSaNVEur78s4eEIxvAza4130_provenance.
• NP964023.RAhB1M7hqlFO4AaLkplxlx7mAQh_NKkJQHVyzhJLOAOB8130_assertion description "[Recent studies have indicated that CD30 is frequently expressed in aggressive systemic mastocytosis and mast cell leukemia but infrequently in indolent systemic mastocytosis, and may be a useful marker for distinguishing these subtypes of systemic mastocytosis from one another.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964023.RAhB1M7hqlFO4AaLkplxlx7mAQh_NKkJQHVyzhJLOAOB8130_provenance.
• NP292342.RAJCo_TmOd5fCm-5mvkQyoeCtExx_P9GWIRQFswtfF6t8130_assertion description "[Recent studies have indicated that CD30 is frequently expressed in aggressive systemic mastocytosis and mast cell leukemia but infrequently in indolent systemic mastocytosis, and may be a useful marker for distinguishing these subtypes of systemic mastocytosis from one another.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292342.RAJCo_TmOd5fCm-5mvkQyoeCtExx_P9GWIRQFswtfF6t8130_provenance.
• NP964024.RAOJaUwUZBd9WyMaa-_emdTirtMg9LLQYNw1rIJOasuLU130_assertion description "[Recent studies have indicated that CD30 is frequently expressed in aggressive systemic mastocytosis and mast cell leukemia but infrequently in indolent systemic mastocytosis, and may be a useful marker for distinguishing these subtypes of systemic mastocytosis from one another.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964024.RAOJaUwUZBd9WyMaa-_emdTirtMg9LLQYNw1rIJOasuLU130_provenance.
• NP964025.RA_AmTYCnZ6VHoxn9vzsDh0t70GoG0JmMuhnqCx9vxKVk130_assertion description "[Recent studies have indicated that CD30 is frequently expressed in aggressive systemic mastocytosis and mast cell leukemia but infrequently in indolent systemic mastocytosis, and may be a useful marker for distinguishing these subtypes of systemic mastocytosis from one another.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964025.RA_AmTYCnZ6VHoxn9vzsDh0t70GoG0JmMuhnqCx9vxKVk130_provenance.